000889014 001__ 889014
000889014 005__ 20220930130301.0
000889014 0247_ $$2doi$$a10.1167/iovs.61.13.37
000889014 0247_ $$2ISSN$$a0146-0404
000889014 0247_ $$2ISSN$$a1552-5783
000889014 0247_ $$2Handle$$a2128/26607
000889014 0247_ $$2pmid$$a33252632
000889014 0247_ $$2WOS$$aWOS:000595313500031
000889014 037__ $$aFZJ-2020-05388
000889014 082__ $$a610
000889014 1001_ $$0P:(DE-Juel1)169371$$aGehlen, Jana$$b0$$ufzj
000889014 245__ $$aBlockade of Retinal Oscillations by Benzodiazepines Improves Efficiency of Electrical Stimulation in the Mouse Model of RP, rd10
000889014 260__ $$aRockville, Md.$$bARVO$$c2020
000889014 3367_ $$2DRIVER$$aarticle
000889014 3367_ $$2DataCite$$aOutput Types/Journal article
000889014 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1611734618_24154
000889014 3367_ $$2BibTeX$$aARTICLE
000889014 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000889014 3367_ $$00$$2EndNote$$aJournal Article
000889014 520__ $$aPurpose: In RP, photoreceptors degenerate. Retinal prostheses are considered a suitable strategy to restore vision. In animal models of RP, a pathologic rhythmic activity seems to compromise the efficiency of retinal ganglion cell stimulation by an electrical prosthesis. We, therefore, strove to eliminate this pathologic activity.Methods: Electrophysiologic recordings of local field potentials and spike activity of retinal ganglion cells were obtained in vitro from retinae of wild-type and rd10 mice using multielectrode arrays. Retinae were stimulated electrically.Results: The efficiency of electrical stimulation was lower in rd10 retina than in wild-type retina and this was highly correlated with the presence of oscillations in retinal activity. Glycine and GABA, as well as the benzodiazepines diazepam, lorazepam, and flunitrazepam, abolished retinal oscillations and, most important, increased the efficiency of electrical stimulation to values similar to those in wild-type retina.Conclusions: Treatment of patients with these benzodiazepines may offer a way to improve the performance of retinal implants in cases with poor implant proficiency. This study may open the way to a therapy that supports electrical stimulation by prostheses with pharmacologic treatment.
000889014 536__ $$0G:(DE-HGF)POF3-552$$a552 - Engineering Cell Function (POF3-552)$$cPOF3-552$$fPOF III$$x0
000889014 588__ $$aDataset connected to CrossRef
000889014 7001_ $$0P:(DE-Juel1)167220$$aEsser, Stefan$$b1
000889014 7001_ $$0P:(DE-HGF)0$$aSchaffrath, Kim$$b2
000889014 7001_ $$0P:(DE-HGF)0$$aJohnen, Sandra$$b3
000889014 7001_ $$0P:(DE-Juel1)186891$$aWalter, Peter$$b4$$ufzj
000889014 7001_ $$0P:(DE-Juel1)131939$$aMüller, Frank$$b5$$eCorresponding author$$ufzj
000889014 773__ $$0PERI:(DE-600)2009858-3$$a10.1167/iovs.61.13.37$$gVol. 61, no. 13, p. 37 -$$n13$$p37 -$$tInvestigative ophthalmology & visual science$$v61$$x1552-5783$$y2020
000889014 8564_ $$uhttps://juser.fz-juelich.de/record/889014/files/Invoice_INV_20_NOV_001084.pdf
000889014 8564_ $$uhttps://juser.fz-juelich.de/record/889014/files/i1552-5783-61-13-37_1606293122.665.pdf$$yOpenAccess
000889014 8767_ $$8INV/20/NOV/001084$$92020-11-05$$d2021-01-27$$eAPC$$jZahlung erfolgt$$zFZJ-2020-04290, 1500USD  / Belegnr 1200159411
000889014 909CO $$ooai:juser.fz-juelich.de:889014$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000889014 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)169371$$aForschungszentrum Jülich$$b0$$kFZJ
000889014 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)186891$$aForschungszentrum Jülich$$b4$$kFZJ
000889014 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131939$$aForschungszentrum Jülich$$b5$$kFZJ
000889014 9131_ $$0G:(DE-HGF)POF3-552$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vEngineering Cell Function$$x0
000889014 9141_ $$y2020
000889014 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-09-09
000889014 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000889014 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINVEST OPHTH VIS SCI : 2018$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000889014 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-09-09
000889014 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-09-09
000889014 920__ $$lyes
000889014 9201_ $$0I:(DE-Juel1)IBI-1-20200312$$kIBI-1$$lMolekular- und Zellphysiologie$$x0
000889014 980__ $$ajournal
000889014 980__ $$aVDB
000889014 980__ $$aI:(DE-Juel1)IBI-1-20200312
000889014 980__ $$aAPC
000889014 980__ $$aUNRESTRICTED
000889014 9801_ $$aAPC
000889014 9801_ $$aFullTexts